Skip to content

Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

Chen-style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02370654
Enrollment
44
Registered
2015-02-25
Start date
2014-03-31
Completion date
2017-07-01
Last updated
2018-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Keywords

COPD, Tai chi, Pulmonary rehabilitation

Brief summary

This study will evaluate the effects of Chen-style Tai Chi compared to conventional exercise in pulmonary rehabilitation for COPD patients. Half of participants will receive the Chen-style Tai Chi intervention, while the other half will receive the conventional exercise intervention. Both groups will receive the same eduction and support during pulmonary rehabilitation.

Interventions

BEHAVIORALTai chi
BEHAVIORALConventional exercise

Sponsors

Saey, Didier, M.D.
CollaboratorINDIV
Maltais, Francois, M.D.
CollaboratorINDUSTRY
Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* FEV1 between 30 and 80% of the predicted normal values * FEV1/FVC ratio \< 70%

Exclusion criteria

* Patients with very severe COPD (GOLD IV); * Patients that had a COPD exacerbations within the preceding 2 weeks of the baseline assessments; * Significant hypoxemia at rest or during exercise (SpO2 \<85%); * Already following a rehabilitation program; * Have physical limitations that compromises participation to a Tai chi and a conventional exercise program

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline dyspnea at 12 weeksBaseline, 12 weeksDyspnea will be assessed using the chronic respiratory questionnaire (CRQ)

Secondary

MeasureTime frameDescription
Change from baseline walking distance at 12 weeks (distance walked during the six-minute walk test)Baseline, 12 weeksThe distance walked during the six-minute walk test will be used to evaluate the functional exercise capacity of all participants at baseline and post-rehabilitation.
Change from baseline exercise capacity at 12 weeks(Endurance time during a constant work rate bicycle ergometry exercise test)Baseline, 12 weeksEndurance time during a constant work rate bicycle ergometry exercise test will be used to evaluate the exercise capacity of all participants at baseline and post-rehabilitation.
Change from baseline isokinetic quadriceps muscle function at 12 weeksBaseline, 12 weeksVoluntary isokinetic quadriceps muscle function will be determined by quantification of force, endurance, and fatigability of the dominant quadriceps during a series of 30 repetitions at an angular velocity of 90°/s of a knee extension test.
Change from baseline isometric quadriceps muscle strength at 12 weeks (force of the dominant quadriceps will be measured during a single magnetic stimulation of the femoral nerve)Baseline, 12 weeksThe force of the dominant quadriceps will be measured during a single magnetic stimulation of the femoral nerve (Twitch force of the quadriceps \[Twq\]) and during a maximum voluntary contraction (MVC).
Change from baseline lung function at week 12 (Spirometry and whole-body plethysmography)Baseline, 12 weeksSpirometry and whole-body plethysmography will be used for baseline and post-training (12 weeks) lung function testing.
Change from baseline quality of life (QoL) at 12 weeksBaseline, 12 weeksIn addition to dyspnea (primary outcome), the CRQ will be used also to measure other physical-functional limitations due to COPD with questions related to fatigue and energy levels.
Change from baseline health status at 12 weeks (determined with the COPD Assessment test (CAT).Baseline, 12 weeksImpact of COPD on a person's life will be determined with the COPD Assessment test (CAT).
Change from baseline balance (Berg Balance Test (BBT) at 12 weeksBaseline, 12 weeksThe Berg Balance Test (BBT) will be used to evaluate the effect of the interventions on patient's balance.
Change from baseline of composite serum and plasma biomarkers at 12 weeksBaseline, 12 weeksDuring the baseline assessment and after the rehabilitation program, blood samples from patients will be taken in order to investigate the effect of the interventions on different biomarkers related to systemic inflammation.
Change from baseline physical activity at 12 weeks (participants will be equipped with a physical activity monitor)Baseline, 12 weeksTo monitor physical activity, participants will be equipped with a physical activity monitor. The device will monitor the daily energy expenditure, the duration of physical activities above the pre-determined intensity level (Metabolic Equivalent of Task (MET) \>3), and also the total daily number of steps.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026